Intellectual Property Owners Association

Serving the Global Intellectual Property Community


Pharmaceutical & Biotechnology Issues Committee


The committee will advise the IPO Board of Directors regarding legislative changes, patent office
policies, regulatory issues and judicial decisions affecting the pharmaceutical and biotechnology
industry. This includes pharmaceuticals subject to the Drug Price Competition and Patent Term
Restoration Act (the Hatch-Waxman Act), the Biologics Price Competition and Innovation Act (the BPCIA
Act), and U.S. counterpart laws and regulations. The Committee’s primary goal is to review proposed
legislative and regulatory initiatives, and proactively submit comments and recommendations to the
Board that reflect the proper balance between generic drug/biosimilar entry and maintaining strong
incentives for the discovery, development and protection of new pharmaceutical products. A secondary
goal of the committee is to monitor and comment upon judicial decisions and proposed patent practice
changes for the education and benefit of IPO members.

Committee Roster

Chair: Paul Golian, Bristol-Myers Squibb Company
Vice Chair: Grantland G. Drutchas, McDonnell Boehnen Hulbert & Berghoff LLP
Vice Chair: Beverley Moore, Borden Ladner Gervais, LLP
Secretary: Kathryn Wade, Kilpatrick Townsend & Stockton LLP
Board Liaison: Cara M. Coburn, Roche, Inc.
Staff Liaison: Samantha J. Aguayo, Intellectual Property Owners Association


 Timothy J. Babcock
 Akros Pharma Inc.

 Aaron F. Barkoff
 McAndrews, Held & Malloy, Ltd.

 Bryan Beel
 Perkins Coie, LLP

 Nicole M. Beeler
 Merck & Co Inc.

 Caryn C. Borg-Breen
 Green Griffith Borg-Breen LLP

 William Boudreaux
 Brinks Gilson & Lione

 Shane Brunner
 Michael Best & Friedrich LLP

 Paul Calvo
 Sterne, Kessler, Goldstein & Fox, PLLC

 Jennifer Robichaux Carter
 Baker Botts LLP

 Cindy Chang
 Alston & Bird LLP

 Aaron Clay
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

 Jean M. Dickman
 Shook, Hardy & Bacon LLP

 Garreth Andrew Duncan
 D Young & Co LLP

 Cassie J. Edgar
 ABS Global, Inc.

 Rachel J. Elsby
 Akin Gump Strauss Hauer & Feld LLP

 Kent Fagan
 Thompson Hine LLP

 Therese Finan
 Dinsmore & Shohl LLP

 Tasha Francis
 Fish & Richardson, PC

 Michael L. Fuller
 Knobbe, Martens, Olson & Bear, LLP

 David A. Gass
 Marshall, Gerstein & Borun LLP

 Maximilienne Giannelli
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

 Jessica Gorczynski
 Womble Bond Dickinson LLP

 Linda Govenlock

 Timothy E. Grimsrud
 Faegre Baker Daniels LLP

 Tom Gumley
 FPA Patent Attorneys Pty Ltd

 Sana Halwani
 Lenczner Slaght

 Bo Han
 Bristol-Myers Squibb Company

 Elisabeth R. Healey
 Vorys, Sater, Seymour and Pease LLP

 Paul J. Higgins
 Johnson & Johnson

 Erica Hines
 Heslin Rothenberg Farley & Mesiti PC

 Sarah Hooson
 Merck & Co Inc.

 Andrew E.J. Hutchinson
 Simmons & Simmons LLP

 Thomas L. Irving
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

 Charlotte Jacobsen
 Ropes & Gray LLP

 Christopher T. Jagoe
 Kirkland & Ellis, LLP

 Andrea Weiss Jeffries
 Jones Day

 Lawrence Kass
 Buchanan Ingersoll & Rooney PC

 Omar Khan
 Wilmer Cutler Pickering Hale and Dorr, LLP

 Nicole Kopinski
 Leydig, Voit & Mayer, Ltd.

 Serge Lapointe
 Fasken Martineau DuMoulin LLP

 Stephanie Adrienne Lodise

 Christopher E. Loh
 Venable, LLP

 Tom Malone

 Ryan L. Marshall
 Brinks Gilson & Lione

 Deborah Martin
 Pfizer Inc.

 Vikram A. Mathrani
 Honigman Miller Schwartz and Cohn LLP

 Eileen McMahon
 Torys LLP

 Aseem V. Mehta
 Bayer Intellectual Property GmbH

 Ryan B. Meyer
 Dorsey & Whitney, LLP

 Dr. Scott Miller
 Thermo Fisher Scientific Inc.

 Pamela Mingo
 Sterne, Kessler, Goldstein & Fox, PLLC

 Tara A. Nealey

 Jeff Nichols
 Brinks Gilson & Lione

 Liliana Nolan
 Mersan, Abogados

 Daniel Orr
 Womble Bond Dickinson LLP

 Keith Orso
 Irell & Manella LLP

 Caroline Ya-Lan Pao
 Jianq Chyun IP Office

 Heather Petruzzi
 Wilmer Cutler Pickering Hale and Dorr, LLP

 Xavier Pillai
 Leydig, Voit & Mayer, Ltd.

 Louisa Pontrelli
 Norton Rose Fulbright

 Filko Prugo
 Ropes & Gray LLP

 Leanne Rakers
 Harness, Dickey & Pierce, P.L.C.

 Robert T. Ramos
 Procopio, Cory, Hargreaves & Savitch LLP

 Jane Remillard
 Nelson Mullins Riley Scarborough, L.L.P

 Irena Royzman
 Patterson Belknap Webb & Tyler LLP

 Hari Santhanam
 Kirkland & Ellis, LLP

 Hassen Sayeed
 O'Melveny & Myers LLP

 Michael Schubert
 Leydig, Voit & Mayer, Ltd.

 Thomas Schulte
 Bayer Intellectual Property GmbH

 Raj Shah
 Johnson & Johnson

 Patricia A. Shatynski
 Merck & Co Inc.

 Teige Sheehan
 Heslin Rothenberg Farley & Mesiti PC

 Sean Sheridan
 Charles River Associates

 Vincent K. Shier

 Brian Shortell
 Ballard Spahr LLP

 Joel Silver
 Gilead Sciences, Inc.

 Kitt Sinden
 Aird & McBurney LP

 Pamela Sisson
 Bayer Intellectual Property GmbH

 Stephany Small
 Buchanan Ingersoll & Rooney PC

 Lauren Stevens
 Dennemeyer & Associates S.A.

 Thomas Thrash
 Vorys, Sater, Seymour and Pease LLP

 Adrian Trioli
 Adrian M Trioli - Intellectual Property

 Jeffrey A. Wolfson
 Haynes and Boone, LLP

 Tina Yang
 Baker Botts LLP

 George C. Yu
 Schiff Hardin LLP

 Richard Zanzalari
 Pfizer Inc.

 Donald L. Zuhn
 McDonnell Boehnen Hulbert & Berghoff LLP

Non-Voting Member:Courtenay C. Brinckerhoff, Foley & Lardner LLP
Non-Voting Member:Julie Burke, Knobbe, Martens, Olson & Bear, LLP
Non-Voting Member:Robert Burrows, Bristows LLP
Non-Voting Member:Carlyn Burton, Osha Liang, LLP
Non-Voting Member:Janet Cord, Ladas & Parry LLP
Non-Voting Member:Kathy Coulter, Bristol-Myers Squibb Company
Non-Voting Member:Erik Drange, 3M Innovative Properties Co.
Non-Voting Member:Dianne Elderkin, Akin Gump Strauss Hauer & Feld LLP
Non-Voting Member:Serena I. Farquharson-Torres, Bristol-Myers Squibb Company
Non-Voting Member:Gloria Fuentes, Merck & Co Inc.
Non-Voting Member:John M. Griem, Jr., Carter Ledyard & Milburn LLP
Non-Voting Member:Emily Johnson, Amgen, Inc.
Non-Voting Member:Robert J. Kajubi, Sanofi
Non-Voting Member:Richard Kurz, Haug Partners LLP
Non-Voting Member:Stacy Lewis, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Non-Voting Member:Toby Mak, Tee & Howe Intellectual Property Attorneys
Non-Voting Member:Mercedes K. Meyer, Drinker, Biddle & Reath, LLP
Non-Voting Member:Brian P. Murphy, Haug Partners LLP
Non-Voting Member:Joshua E. Ney, Brinks Gilson & Lione
Non-Voting Member:Corey Salsberg, Novartis
Non-Voting Member:J. Eric Thies, Merck & Co Inc.
Non-Voting Member:Holger Carl Tostmann, Wallinger Ricker Schlotter Tostmann
Non-Voting Member:Camille Turner, Haug Partners LLP
Non-Voting Member:Wenwen Wang, Advance China IP Law Office
Non-Voting Member:Andrew W. Williams, McDonnell Boehnen Hulbert & Berghoff LLP
Non-Voting Member:Yingying Zeng, Merck & Co Inc.

If you are an IPO Member, you may login to view committee contact information by clicking here.